InvestSMART

Lumos Diagnostics Holdings Limited (ASX: LDX) - Announcements

- Current share price for LDX : $0.083

ASX company news and announcements for Lumos Diagnostics Holdings Limited (LDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Lumos Diagnostics Holdings Limited (LDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Lumos Diagnostics Holdings Limited (LDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Lumos Diagnostics Holdings Limited (LDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$81 Application for quotation of securities - LDX 20 Oct 2026 9:04AM $0.093 $0.083 fallen by 10.75%
$81 Q1 FY27 Quarterly Results Date & Webinar Invitation 19 Oct 2026 11:28AM $0.088 $0.083 fallen by 5.68%
$81 Final Director's Interest Notice - LM 13 Oct 2026 2:43PM $0.093 $0.083 fallen by 10.75%
$81 Initial Director's Interest Notice - AS 13 Oct 2026 2:43PM $0.093 $0.083 fallen by 10.75%
$81 Notice of Annual General Meeting and Proxy Form 12 Oct 2026 4:20PM $0.098 $0.083 fallen by 15.31%
$81 Lumos Diagnostics Board Changes 12 Oct 2026 11:32AM $0.097 $0.083 fallen by 14.43%
$81 Notification of cessation of securities - LDX 9 Oct 2026 9:40AM $0.105 $0.083 fallen by 20.95%
$81 Section 708A Cleansing Statement 30 Sep 2026 9:16AM $0.105 $0.083 fallen by 20.95%
$81 Application for quotation of securities - LDX 30 Sep 2026 9:14AM $0.105 $0.083 fallen by 20.95%
$81 Change in substantial holding from RYD 15 Sep 2026 4:40PM $0.110 $0.083 fallen by 24.55%
$81 Section 708A Cleansing Statement 15 Sep 2026 12:38PM $0.110 $0.083 fallen by 24.55%
$81 Application for quotation of securities - LDX 15 Sep 2026 12:37PM $0.110 $0.083 fallen by 24.55%
$81 FebriDx Commercial Traction Continues Across US Accounts 15 Sep 2026 9:26AM $0.100 $0.083 fallen by 17%
$81 Section 708A Cleansing Statement 1 Sep 2026 1:50PM $0.100 $0.083 fallen by 17%
$81 Application for quotation of securities - LDX 1 Sep 2026 1:48PM $0.100 $0.083 fallen by 17%
$81 Change of Director's Interest Notice - DW 1 Sep 2026 1:04PM $0.100 $0.083 fallen by 17%
$81 Appendix 4G and Corporate Governance Statement 26 Aug 2026 10:06AM $0.105 $0.083 fallen by 20.95%
$81 FY26 Full Year Results Announcement 26 Aug 2026 9:44AM $0.100 $0.083 fallen by 17%
$81 FY26 Annual Report 26 Aug 2026 9:41AM $0.100 $0.083 fallen by 17%
$81 FY26 Appendix 4E 26 Aug 2026 9:22AM $0.100 $0.083 fallen by 17%
$81 Lumos to Present at 20th Bioshares Biotech Summit 7 Aug 2026 11:02AM $0.120 $0.083 fallen by 30.83%
$81 Lumos Receives FebriDx Order from PHASE Scientific 4 Aug 2026 9:04AM $0.105 $0.083 fallen by 20.95%
$81 Lumos Secures Distribution for FebriDx in Romania 30 Jul 2026 9:38AM $0.100 $0.083 fallen by 17%
$81 Change of Director's Interest Notice - DW 28 Jul 2026 12:42PM $0.103 $0.083 fallen by 19.02%
$81 Section 708A Cleansing Statement 28 Jul 2026 9:40AM $0.100 $0.083 fallen by 17%

1 - 25 of 564 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.